MRI changes in cerebrotendinous xanthomatosis after treatment with chenodeoxycholic acid

被引：1
|
作者：
Lui, CC
Chang, WN
机构：
[1] Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan
[2] Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan
来源：
RIVISTA DI NEURORADIOLOGIA | 1998年 / 11卷
关键词：
cerebrotendinous xanthomatosis; chenodeoxycholic acid; magnetic resonance imaging;
D O I：
10.1177/19714009980110S203
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
We report serial changes in MRI findings in three siblings of biochemically and clinically proven cerebrotendinous xanthomatosis (CTX) after treatment with chenodeoxycholic acid (CDCA) 750 mg/day orally for seven years. Clinical and electrophysiological studies are also assessed Electroencephalography (EEG) has improved dramatically whereas the magnetic resonance image(MRI) shows only slight change.
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [1] TREATMENT OF CEREBROTENDINOUS XANTHOMATOSIS WITH CHENODEOXYCHOLIC ACID
    PEDLEY, TA
    EMERSON, RG
    WARNER, CL
    ROWLAND, LP
    SALEN, G
    ANNALS OF NEUROLOGY, 1985, 18 (04) : 517 - 518
  • [2] Chenodeoxycholic treatment of cerebrotendinous xanthomatosis
    Samenuk, P
    Koffman, BM
    NEUROLOGY, 2001, 56 (05) : 695 - 695
  • [3] Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid
    F. Ginanneschi
    A. Mignarri
    M. Mondelli
    G. N. Gallus
    M. Del Puppo
    S. Giorgi
    A. Federico
    A. Rossi
    M. T. Dotti
    Journal of Neurology, 2013, 260 : 268 - 274
  • [4] Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid
    Ginanneschi, F.
    Mignarri, A.
    Mondelli, M.
    Gallus, G. N.
    Del Puppo, M.
    Giorgi, S.
    Federico, A.
    Rossi, A.
    Dotti, M. T.
    JOURNAL OF NEUROLOGY, 2013, 260 (01) : 268 - 274
  • [5] Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis
    Caroppo, Paola
    D'Agata, Federico
    Mignarri, Andrea
    Stromillo, Maria Laura
    Dotti, Maria Teresa
    Mongini, Tiziana
    NEUROLOGICAL SCIENCES, 2013, 34 (09) : 1693 - 1696
  • [6] Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis
    Paola Caroppo
    Federico D’Agata
    Andrea Mignarri
    Maria Laura Stromillo
    Maria Teresa Dotti
    Tiziana Mongini
    Neurological Sciences, 2013, 34 : 1693 - 1696
  • [7] LONG-TERM TREATMENT OF CEREBROTENDINOUS XANTHOMATOSIS WITH CHENODEOXYCHOLIC ACID
    BERGINER, VM
    SALEN, G
    SHEFER, S
    NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (26): : 1649 - 1652
  • [8] REDUCED CHENODEOXYCHOLIC ACID SYNTHESIS IN CEREBROTENDINOUS XANTHOMATOSIS
    SALEN, G
    SHEFER, S
    TINT, GS
    ARTERIOSCLEROSIS, 1983, 3 (05): : A494 - A494
  • [9] TREATMENT OF CEREBROTENDINOUS XANTHOMATOSIS - EFFECTS OF CHENODEOXYCHOLIC ACID, PRAVASTATIN, AND COMBINED USE
    KURIYAMA, M
    TOKIMURA, Y
    FUJIYAMA, J
    UTATSU, Y
    OSAME, M
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 125 (01) : 22 - 28
  • [10] Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment
    Hidde H. Huidekoper
    Frédéric M. Vaz
    Aad Verrips
    Annet M. Bosch
    European Journal of Pediatrics, 2016, 175 : 143 - 146
12345